Group 1 - The A-share market has quietly risen above 4100 points at the beginning of 2026, leading to regrets among investors who took profits at the end of the previous year [1] - The year 2025 was marked as a pivotal moment for China's technology industry, showcasing significant breakthroughs and a strong market response, pushing the market above 4000 points [5] - The technology sector is expected to continue its dynamic growth in 2026, with advancements in artificial intelligence, space economy, commercial aerospace, life sciences, and renewable energy [4][6] Group 2 - The technology narrative remains compelling, with concerns about potential bubbles in tech stocks being addressed by market performance, showing over 10% growth in tech stocks at the start of 2026 [8][10] - The current AI wave is not seen as an irrational bubble but rather a result of national strategic planning and market sentiment, with domestic demand supporting a more controllable bubble risk compared to overseas tech giants [10] - Active fund managers with the ability to select stocks in the technology sector will be increasingly important as the market shifts towards more selective and structural growth in 2026 [11][12] Group 3 - Investment opportunities in AI are expected to focus on the integration of AI with existing ecosystems and the enhancement of productivity across various sectors [19][20] - The commercial aerospace sector is projected to see significant developments, particularly in satellite networking and reusable rocket technology, which could drastically reduce launch costs [21] - The pharmaceutical sector is anticipated to shift from speculative pricing to more data-driven valuations as policies and payment structures become clearer [21]

近期，科技产业成为市场关注焦点，多领域传来积极信号推动相关板块活跃度提升。AI领域，英伟达 H20对华销售重启、云厂商资本开支增长预期升温，带动AI硬件、CPO等细分赛道走强；人形机器人赛 道受行业大会及技术进展催化，市场关注度持续攀升；半导体板块则因国产替代进程加速，叠加华为等 企业在计算架构上的创新突破，展现出强劲增长动能。与此同时，创新药板块凭借"大额对外授权"等逻 辑演绎，军工板块因技术实力获国际认可，共同构成科技及相关领域的投资热点矩阵。 2025年二季度基金季报已经披露结束，诺安基金科技组多位基金经理基于对产业趋势的深度研判。在创 新药领域，诺安基金科技组的布局尤为引人瞩目。基金经理唐晨管理的诺安精选价值混合基金，战略性 布局A股和H股创新药板块，精准捕捉行业"时代大单品"的核心驱动逻辑。唐晨在二季报中强调，其核 心选股策略是"寻找与时代相契合的超级大单品"，敢于在市场调整期识别被低估的"期权价值"机会。这 一策略成效斐然，截至2025年6月30日，诺安精选价值混合A2025年以来净值增长率为61.88%，同期比 较基准为5.74%，(数据来源，诺安基金，托管行已复核)据银河证券2025年7月20 ...